Mylan Laboratories Inc. Declares Quarterly Preferred Stock Dividend
Published: Aug 01, 2008
PITTSBURGH, July 31 /PRNewswire-FirstCall/ -- Mylan Inc. today announced that in accordance with its 2.139 million preferred stock issuance, the company has declared its quarterly dividend of $16.25 per share (based on the annual dividend rate of 6.5% and a liquidation preference of $1,000.00 per share) payable on August 15, 2008, to holders of preferred stock of record as of August 1, 2008.
Mylan Inc., with operations in more than 90 countries, ranks among the leading diversified generic and specialty pharmaceutical companies in the world. The company maintains one of the industry's broadest-and highest quality-product portfolios, supported by a robust product pipeline; owns a controlling interest in the world's second largest active pharmaceutical ingredient manufacturer; and operates a specialty business focused on respiratory and allergy therapies.
CONTACT: Media, Michael Laffin, or Investors, Dan Crookshank, both of
Mylan Inc., +1-724-514-1813
Web site: http://www.mylan.com/